Russell Angus C. 4/A
4/A · Revance Therapeutics, Inc. · Filed May 13, 2022
Insider Transaction Report
Form 4/AAmended
Russell Angus C.
Director
Transactions
- Award
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 totalExercise: $18.12Exp: 2032-05-03→ Common Stock (10,756 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Mr. Russell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy.